Balantidiasis Treatment and Diagnosis Market Covering Size, Growth Factors, Demand-Sales Analysis by Major Manufacturers
Balantidiasis Treatment and Diagnosis Industry Synopsis:
Balantidiasis is a disease caused by the bacterium
Balantidium coli which mainly affects the large intestine. The disease spreads
through fecal-oral route due to the contamination of food and water by the
feces of pig or human. Improper sanitary conditions and unsafe drinking water
are important aspects for the spread of the diseases.
Rising
prevalence of gastrointestinal disorders, increasing number of patients and
availability of treatment of balantidiasis drives the growth of the market.
Additionally, the lack of hygiene and sanitation in the rural areas of
developing countries is one of the many factors which affect the spread of this
disease. Furthermore, rising awareness about the diseases transmitted through
fecal-oral route influences the market growth. Competition among existing
market players restrict the entry of new players.
The
global balantidiasis market is expected to grow at a CAGR of 2.1% during the
forecast period.
Avail
FREE Sample at: https://www.marketresearchfuture.com/sample_request/4725
The market is driven by the increasing prevalence of
communicable diseases in rural areas for developing countries. In addition,
increasing research and development activities, technological advancements to
identify the causes and risk factors for transmission of infectious agents and
developing new solutions to minimize patient exposure is another major driver,
fuelling the global market growth.
Competitive Analysis:
Some of the key players in the global market are –
·
Pfizer (U.S.)
·
Abbott (U.S.)
·
GlaxoSmithKline plc. (U.K)
·
BD (U.S.)
·
Sandoz International GmbH (Germany)
·
Amneal Pharmaceuticals LLC. (U.S.)
·
Akorn Inc. (U.S.)
·
PharmaDerm A division of Fougera
Pharmaceuticals Inc. (U.S.).
Segmental Analysis:
The global balantidiasis market is
segmented on the basis of diagnosis, treatment, and end user.
On the basis of diagnosis,
the market is segmented into stool examination, sigmoidoscopy, biopsy, and
others.
On the basis of treatment,
the market is segmented into antibiotics, appendectomy, and others. Antibiotics
segment is further divided into tetracycline, metronidazole, and others.
On the basis of end user,
the market is segmented into hospitals, clinics, diagnostic centers, and
others.
Intended
Audience
- Drug
Manufacturers
- Drug
Suppliers
- Medical
Research Laboratories
- Research and
Development (R&D) Companies
- Market
Research and Consulting Service Providers
- Potential Investors
Brows
Complete Detailed Research Report at https://www.marketresearchfuture.com/reports/balantidiasis-market-4725
Regional
Analysis:
The market is found to be
steady in Americas. Emphasis on healthy lifestyle and prevention of
communicable diseases also influence the growth of the market. The prevalence
of the disease is found to the higher rural South America than North American
countries.
In Europe, the prevalence
of balantidiasis is found to be low which is attributed to stringent
regulations governing the manufacturing of food products and low prevalence of
gastrointestinal diseases.
In Asia Pacific, the
prevalence of balantidiasis is found increasing steadily as a result of
increasing prevalence of colitis, chronic diarrhea, and, deep intestinal
ulcerations, poor healthcare system, and availability of treatment options for
various gastrointestinal diseases. According to the data from GLOBOCAN, in
2012, the age-standardized rate (ASR) of incidence of gastrointestinal diseases
in Asia Pacific was 15.8 and mortality was 11.7 per 100,000. According to World
Health Organization (WHO), the geriatric population in China in the year 2013
was 22.6 million which is expected to show a massive growth to 90.4 million in
2050.
In the Middle East
& Africa, gastrointestinal diseases are a major cause of disability.
The infection is mainly acquired due to ingestion of food and water
contaminated by cysts.
About Market Research
Future:
At Market Research Future (MRFR), we enable
our customers to unravel the complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
In order to stay updated with technology
and work process of the industry, MRFR often plans & conducts meet with the
industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment